Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.
External link for Cingulate Inc.
1901 W. 47th Place
Suite 310
Kansas City, Kansas 66205, US
6 South Street
Morristown, NJ 07960, US
Cingulate Inc. reposted this
#ICYMI: Cingulate's CEO Shane Schaffer appeared on Benzinga's All Access Live today with ADHD Key Opinion Leader Dr. Ann Childress, President at Center for Psychiatry and Behavioral Medicine, Inc. #ADHD #CING #NASDAQ #ADHDawareness #Cingulate https://lnkd.in/gUpdBrnC https://lnkd.in/gPdHjxvM
#ICYMI: Cingulate's CEO Shane Schaffer appeared on Benzinga's All Access Live today with ADHD Key Opinion Leader Dr. Ann Childress, President at Center for Psychiatry and Behavioral Medicine, Inc. #ADHD #CING #NASDAQ #ADHDawareness #Cingulate https://lnkd.in/gUpdBrnC https://lnkd.in/gPdHjxvM
Cingulate Receives FDA Clearance To Apply For New ADHD Drug Approval #ADHD #CING #ADHDAWARENESS #NASDAQ www.cingulate.com https://lnkd.in/gem6iMqu
"This research underscores the importance of considering cognitive function alongside behavioral treatment for ADHD." #Cingulate #adhd #CING #Nasdaq https://lnkd.in/eGhTnFRy
"Increased awareness is leading to more diagnoses." #adhd #cingulate #adhdawareness #CING #NASDAQ www.cingulate.com https://lnkd.in/gRKKC8zq
Discover the valuable insights into Cingulate's strategy for expanding ADHD awareness. https://lnkd.in/gUETVbEB https://lnkd.in/d43VhGHm
Discover how Cingulate's cutting-edge technology is making a positive impact to address this global concern. #Cingulate #ADHD #CING #Nasdaq https://lnkd.in/gEzs863m https://lnkd.in/d3Kih9bN
We are dedicated to finding an improved solution for this escalating issue. Learn more: https://lnkd.in/gEzs863m https://lnkd.in/gTSarMin
Cingulate Inc. reposted this
We are proud to announce that Cingulate Chief Science Officer Raul Silva, MD, has been selected as one of the Top 1% of America's Most Honored Doctors for 2024 by the American Registry. Congratulations Raul on this special honor!
Cingulate Inc. reposted this
We are proud to announce that Cingulate Chief Science Officer Raul Silva, MD, has been selected as one of the Top 1% of America's Most Honored Doctors for 2024 by the American Registry. Congratulations Raul on this special honor!